Page last updated: 2024-09-03

imatinib mesylate and Chronic Idiopathic Intestinal Pseudo-Obstruction

imatinib mesylate has been researched along with Chronic Idiopathic Intestinal Pseudo-Obstruction in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Agud Fernández, M; Díaz Pedroche, C; Gómez-Martín, C; López López, F1

Other Studies

1 other study(ies) available for imatinib mesylate and Chronic Idiopathic Intestinal Pseudo-Obstruction

ArticleYear
Concurrent inflammatory bowel disease and gastrointestinal stromal tumor.
    Gastroenterologia y hepatologia, 2018, Volume: 41, Issue:5

    Topics: Aged, 80 and over; Combined Modality Therapy; Crohn Disease; Fatal Outcome; Gastrointestinal Stromal Tumors; Humans; Ileal Neoplasms; Imatinib Mesylate; Immunosuppressive Agents; Intestinal Obstruction; Intestinal Pseudo-Obstruction; Jejunal Neoplasms; Male; Middle Aged; Peritoneal Neoplasms; Sunitinib

2018